Transforming Growth Factor-β Soluble Receptor III human - Analytical Products / Alfa Chemistry

CAT	IAR4248687
MDL Number	MFCD01324821

Description	>97% (SDS-PAGE), recombinant, expressed in NSO cells, lyophilized powder
Assay	>97% (SDS-PAGE)
Form	lyophilized powder; predicted mol wt 84 kDa
Impurity Content	endotoxin, tested
Size	0.1MG
Storage Conditions	−20°C

1

[Construction and Expression of the Eukaryotic Expression Vector Containing Human Soluble Transforming Growth Factor Beta Receptor II]

Xiao-hua Yang, Li-huang Zhang, Li-yun Shi, Hang-ping Yao, Zi-yang Yu

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2004 Nov;33(6):504-8.

PMID: 15586407

1

A Soluble Transforming Growth Factor Beta Type III Receptor Suppresses Tumorigenicity and Metastasis of Human Breast Cancer MDA-MB-231 Cells

A Bandyopadhyay, Y Zhu, M L Cibull, L Bao, C Chen, L Sun

Cancer Res. 1999 Oct 1;59(19):5041-6.

PMID: 10519421

1

Glioma Gene Therapy With Soluble Transforming Growth Factor-Beta Receptors II and III

Ulrike Naumann, Philipp Maass, Anne-Kathrin Gleske, Steffen Aulwurm, Michael Weller, Guenter Eisele

Int J Oncol. 2008 Oct;33(4):759-65.

PMID: 18813789

1

Impaired Autophagy and APP Processing in Alzheimer's Disease: The Potential Role of Beclin 1 Interactome

Antero Salminen, Kai Kaarniranta, Anu Kauppinen, Johanna Ojala, Annakaisa Haapasalo, Hilkka Soininen, Mikko Hiltunen

Prog Neurobiol. Jul-Aug 2013;106-107:33-54.

PMID: 23827971

1

Loss of Type III Transforming Growth Factor Beta Receptor Expression Increases Motility and Invasiveness Associated With Epithelial to Mesenchymal Transition During Pancreatic Cancer Progression

Kelly J Gordon, Mei Dong, Elizabeth M Chislock, Timothy A Fields, Gerard C Blobe

Carcinogenesis. 2008 Feb;29(2):252-62.

PMID: 17999987

* Products or Services Interested: Transforming Growth Factor-β Soluble Receptor III human ()
* Your question
* Name
* Email
Verification Code